In the study, In Vivo Bioluminescence Tomography-Guided Radiation Research Platform for Pancreatic Cancer: An Initial Study Using Subcutaneous and Orthotopic Pancreatic Tumor Models, investigation on subcutaneous and orthotopic models displayed the significance of Muriglo BLT-guidance for precise irradiation research using SARRP.
Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at ACRO Summit 2025 in Las Vegas
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
